The independent source for health policy research, polling, and news.
281 - 300 of 697 Results
A study ordered by the Food and Drug Administration failed to prove that Makena, the only drug approved to prevent premature birth, is effective. While a panel of experts has recommended withdrawing the drug’s approval, many doctors are wary.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
California lawmakers are proposing ambitious health care ideas, from creating a state generic drug label to banning the sale of flavored e-cigarette products. Even though Democrats control state government, they’re likely to face pushback from powerful health care industry groups like hospitals.
Democratic presidential candidates also returned to now-familiar themes in debating the differences between "Medicare for All" and more incremental reforms.
Calculations are complicated, but correct.
The impact of the Trump administration’s health policies is not as clear-cut as the president’s reelection campaign suggests.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
‘Medication insecurity’ is a thing.
A federal appeals court in New Orleans has agreed with a lower court that a key piece of the Affordable Care Act is unconstitutional. But it is sending the case back to the lower-court judge to decide how much of the rest of the law can stand. Also, Congress is leaving town after finishing work on a major spending bill that includes many changes to health policy. Margot Sanger-Katz of The New York Times, Kimberly Leonard of the Washington Examiner and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this and more.
The administration’s proposed rule to allow states to bring in prescription medications isn’t expected to provide immediate relief.
KHN correspondent Shefali Luthra was among the guests on the podcast "Today, Explained" to talk about PrEP.
After my husband had a bike accident, we were subjected to medical bills that no one would accept if they had been delivered by a contractor, or a lawyer or an auto mechanic. Such charges are sanctioned by insurers, which generally pay because they have no way to know whether you received a particular item or service — and it’s not worth their time to investigate the millions of medical interactions they write checks for each day.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
KHN's Emmarie Huetteman appeared on PBS NewsHour to discuss efforts on Capitol Hill to curb the cost of prescription drugs.
The House passed legislation that would give federal workers 12 weeks of paid parental leave. The measure appears headed for passage in the Senate, and President Donald Trump has promised to sign the measure into law. Meanwhile, House and Senate lawmakers have a tentative deal on surprise medical bills, but don’t count on a compromise just yet. Joanne Kenen of Politico, Kimberly Leonard of the Washington Examiner and Emmarie Huetteman of Kaiser Health News join guest host Mary Agnes Carey of KHN to discuss this and more. And for “extra credit,” the panelists offer their favorite health stories of the week they think you should read, too.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
The annual accounting of national health spending is out. And the 2018 health bill for the U.S. was $3.6 trillion, consuming nearly a fifth of the nation’s economy. Meanwhile, Congress is nearing the end of the year without having finished either its annual spending bills or several other high-priority health items. Kimberly Leonard of the Washington Examiner, Joanne Kenen of Politico and Mary Agnes Carey of Kaiser Health News join KHN’s Julie Rovner to discuss this and more. Also, Rovner interviews KHN’s Markian Hawryluk about the latest KHN-NPR “Bill of the Month.”
The pharmaceutical industry’s argument that capping drug prices would compromise drug innovation stands “on very shaky ground.”
© 2026 KFF